Scarica l'app Stockscreener
13.73
36.62%
3.68
Dopo l'orario di chiusura:
13.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Precedente Chiudi:
$10.05
Aprire:
$15.32
Volume 24 ore:
26.78M
Relative Volume:
6.18
Capitalizzazione di mercato:
$979.75M
Reddito:
-
Utile/perdita netta:
$-192.96M
Rapporto P/E:
-4.1606
EPS:
-3.3
Flusso di cassa netto:
$-167.04M
1 W Prestazione:
+52.05%
1M Prestazione:
+57.45%
6M Prestazione:
+573.04%
1 anno Prestazione:
+444.84%
Intervallo 1D:
$13.43
$15.34
Intervallo di 1 settimana:
$7.08
$25.00
Portata 52W:
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Nome
Ventyx Biosciences Inc
Settore
Industria
Telefono
(760) 407-6511
Indirizzo
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Confronta VTYX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
13.73 | 717.15M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-05 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Downgrade | Stifel | Buy → Hold |
| 2023-11-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Wells Fargo | Overweight |
| 2022-12-19 | Iniziato | Goldman | Buy |
| 2022-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-07 | Iniziato | Stifel | Buy |
| 2022-09-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-09 | Iniziato | Credit Suisse | Outperform |
| 2022-03-31 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-15 | Iniziato | Jefferies | Buy |
| 2021-11-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Eli Lilly confirms plan to buy Ventyx Biosciences in $1.2 billion deal - MSN
Eli Lilly (LLY) Acquires Ventyx Biosciences for $1.2 Billion - GuruFocus
Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14 - TechStock²
Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs - BioPharma Dive
Eli Lilly to buy Ventyx Biosciences for $1.2bn - MLex
Eli Lilly to Acquire Ventyx Biosciences in Cash Deal - TipRanks
Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus - TechStock²
Eli Lilly (LLY) Set to Acquire Ventyx Biosciences in Cash Deal - GuruFocus
Eli Lilly, IBD Stock Of The Day, Offers Two Entries On Rumored Buyout Rally - Investor's Business Daily
Lilly confirms $1.2B takeover of Ventyx Biosciences - breakingthenews.net
Eli Lilly to acquire Ventyx Biosciences in $1.2B deal - Axios
Eli Lilly to buy Ventyx Biosciences for $1.2 billion - Reuters
Lilly to pay $1.2B for Ventyx and its NLRP3 drugs - Endpoints News
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - PR Newswire
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal - Stocktwits
Eli Lilly Shares Surge On Report Of Potential Ventyx Acquisition - Benzinga
Lilly in talks to buy Ventyx Biosciences for more than $1B, WSJ reports - Indianapolis Business Journal
Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more - CNBC
Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage - TechStock²
Eli Lilly (LLY) Nears $1 Billion Acquisition of Ventyx Biosciences (VTYX) - GuruFocus
BRIEF—Ventyx rockets on reports of Lilly buyout - The Pharma Letter
Eli Lilly nears deal for Ventyx Biosciences at $14/shareWSJ - MSN
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday - Benzinga
Ventyx Biosciences stock skyrockets nearly 70% after Eli Lilly offer - medwatch.com
Exclusive | Eli Lilly Nears Deal for Biotech Ventyx - The Wall Street Journal
Stock Movers: Ventyx, Mobileye, Strategy - Bloomberg.com
Stock Market Today: Dow Futures Up, S&P 500 And Nasdaq Slip As ADP Jobs Data Signals Modest Rebound— Mobileye, Penguin Solutions In Focus (UPDATED) - Benzinga
Ventyx Biosciences (VTYX) Stock: Eli Lilly in Advanced Acquisition Talks Worth Over $1 Billion - Blockonomi
Strategy, Sandisk, Warner Bros., Mobileye, First Solar, Ventyx, and More Market Movers - Barron's
Ventyx Biosciences said to be in takeover talks with Eli Lilly, shares surge - Sharecast.com
Is Lilly negotiating to buy Ventyx Bio? - Pharmaphorum
Morning Market Movers: VTYX, CDIO, GLUE, EMAT See Big Swings - RTTNews
Ventyx Biosciences Surges On Eli Lilly Buyout Speculation - Nasdaq
Biggest stock movers Wednesday: VTYX, MBLY, and more (NASDAQ:MBLY) - Seeking Alpha
Eli Lilly Nears Deal to Buy Ventyx Biosciences for Over $1 Billion - Yahoo Finance
These stocks are moving the most today: Strategy, SanDisk, Ventyx Biosciences, Mobileye, and more - MSN
Strategy, Sandisk, Ventyx Biosciences, Mobileye, Cal-Maine Foods, and More Movers - Barron's
Eli Lilly Is Closing In on Deal With Biotech Ventyx, WSJ Says - Bloomberg.com
Trending tickers: Micron, Sandisk Corporation, Ventyx Biosciences, BP and Reckitt - Yahoo Finance UK
These Stocks Are Moving the Most Today: Strategy, Sandisk, Ventyx Biosciences, Mobileye, and More -- Barrons.com - 富途牛牛
Ventyx Biosciences (VTYX) Stock: Eli Lilly Acquisition Talks Send Shares Soaring 62% - CoinCentral
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal - Medical Dialogues
Biggest stock movers Wednesday: VTYX, MBLY, and more - MSN
Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz - TechStock²
Ventyx Biosciences soars as report says Eli Lilly eyes $1 billion acquisition - TradingView — Track All Markets
M&A News: Ventyx Biosciences Stock (VTYX) Rallies on News of Potential Acquisition by Eli Lilly - TipRanks
Stocks to Watch Wednesday: Strategy, Applied Digital, Ventyx, Mobileye - The Wall Street Journal
UBS initiates Ventyx Biosciences stock with Buy rating, $20 price target - Investing.com Canada
Ventyx Biosciences Stock Pre-Market (+63%) : Unconfirmed LLY Takeover Rumors - Trefis
Ventyx BiosciencVentyx Biosciences Stock Jumps 56% After Hours On Reports Of $1 Billion Eli Lilly Buyout - Stocktwits
Lilly in talks to buy Ventyx Biosciences for more than $1 billion - ETPharma.com
Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):